Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants

• Auteurs principaux: Mercedes Macías-Parra (Auteur), Patricia Vidal-Vázquez (Auteur), Jesús Reyna-Figueroa (Auteur), Miguel Ángel Rodríguez-Weber (Auteur), Hortensia Moreno-Macías (Auteur), Inés Hernández-Benavides (Auteur), Sofía Fortes-Gutiérrez (Auteur), Vesta Louise Richardson (Auteur), Paola Vázquez-Cárdenas (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

IntroductionRotavirus-associated diarrheal diseases significantly burden healthcare systems, particularly affecting infants under five years. Both Rotarix™ (RV1) and RotaTeq™ (RV5) vaccines have been effective but have distinct application schedules and limited interchangeability data. This study ai...